CHART vs Conventional Radiotherapy in Cancer Treatment
Author Information
Author(s): MI Saunders, S Dischel, A Barrett, MKB Parmar, A Harvey, D Gibson
Primary Institution: Marie Curie Research Wing for Oncology, Centre for Cancer Treatment, Mount Vernon Hospital
Hypothesis
Cellular repopulation is important as a cause of failure in radiotherapy.
Conclusion
The CHART regimen showed improved survival in non-small-cell lung cancer patients compared to conventional treatment.
Supporting Evidence
- 30% of CHART patients were alive at 2 years compared to 20% in the control group.
- CHART showed a trend for improved local tumor control with increasing tumor stage.
- Early reactions were more severe with CHART but subsided quickly.
Takeaway
This study tested a new way to give radiation therapy that takes less time and found it helps some cancer patients live longer.
Methodology
The study compared CHART with conventional radiotherapy in a randomized controlled trial involving patients with head and neck cancer and non-small-cell lung cancer.
Limitations
The study is an interim report and further analysis is needed as data mature.
Participant Demographics
Patients included were over 18 years old with head and neck cancer or non-small-cell lung cancer.
Statistical Information
P-Value
0.006
Confidence Interval
0.61-0.93
Statistical Significance
p=0.006
Want to read the original?
Access the complete publication on the publisher's website